Parlodel

In some countries, this medicine may only be approved for veterinary use.

In the US, Parlodel (bromocriptine systemic) is a member of the following drug classes: dopaminergic antiparkinsonism agents, prolactin inhibitors and is used to treat Acromegaly, Hyperprolactinemia and Parkinson's Disease.

US matches:

• Parlodel

UK matches:

• Parlodel
• PARLODEL 1 mg Tablets (SPC)
• Parlodel 10 mg capsules (SPC)
• Parlodel 2.5mg Tablets (SPC)
• Parlodel 5mg Capsules (SPC)

Ingredient matches for Parlodel

Bromocriptine

Bromocriptine is reported as an ingredient of Parlodel in the following countries:

• Peru


• Turkey

Bromocriptine mesilate (a derivative of Bromocriptine) is reported as an ingredient of Parlodel in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Bangladesh


• Belgium


• Brazil


• Chile


• China


• Colombia


• Czech Republic


• Denmark


• Egypt


• Estonia


• Ethiopia


• Finland


• France


• Ghana


• Greece


• Hong Kong


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Japan


• Jordan


• Kenya


• Kuwait


• Lebanon


• Libya


• Malaysia


• Mexico


• Netherlands


• Nigeria


• Norway


• Oman


• Peru


• Philippines


• Poland


• Portugal


• Qatar


• Russian Federation


• Saudi Arabia


• Singapore


• South Africa


• Spain


• Sri Lanka


• Sudan


• Switzerland


• Syria


• Taiwan


• Tanzania


• Thailand


• United Arab Emirates


• United Kingdom


• United States


• Venezuela


• Yemen


• Zimbabwe

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.